An open clinical trial on teh efficacy of H-AL pollens (Grass mixture I) administered orally and sublingually in patients with indicated allergen immunotherapy (AIT) with Type I allergy mediated by IgE antibodies (pollens allergy), enrolled in the clinical trial according to the protocol MS01092001 -

SEVAPHARMA a.s.0 个研究点目标入组 72 人开始时间: 2004年8月20日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•1.Voluntarily signed informed consent after a complete infromation of teh subject.
•2.Subject, who properly finished the clinical trial according to the protocol MS01092001.
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years)
•F.1.3.1 Number of subjects for this age range

•1.Subject, who did not properly finish the clinical trial according to the protocol MS01092001.
•2.Pregnant women and women in lactation.
•3.Subject unable of cooperation or irresponsible.
•4.Drugs or alcohol addict.
•5.Not willing to sign the informed consent.

发起方

SEVAPHARMA a.s.